The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Interferon signalling network in innate defence
Abstract
Interferons (IFNs) elicit multifaceted effects in host innate defence. Accumulating evidence revealed that not only the first identified Jak-Stat pathway but also other newly found signalling pathways are required for the induction of versatile responses by IFNs. In particular, type I IFNs are inducible by viral infection through the recognition of pathogen-associated molecules by pattern recognition receptors, and the induction of multiple IFN-stimulated genes through the activation of type I IFN signalling confers antiviral and immunomodulatory activities. Any step in this process is often targeted by viruses for their immuno-evasion. The regulatory function of constitutive IFN-alpha/beta signalling has been recognized in terms of its boosting effect on cellular responsiveness in host defence systems. Further comprehensive understanding of IFN signalling may offer a better direction to unravelling the complex signalling networks in the host defence system, and may contribute to their more effective therapeutic applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 9×
“…of these Jak PTKs, which then phosphorylate their downstream substrates, which are two members of the family of signal transducers and activators of transcription (Stats), namely, Stat1 and Stat2 (Darnell et al., 1994; Ihle and Kerr, 1995; Schindler and Darnell, 1995; Stark et al., 1998).”
BackgroundInfluentialHOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 3,929
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Seth, R. B., Sun, L., Ea, C.-K., & Chen, Z. J. (2005) · Cell · doi:10.1016/j.cell.2005.08.012 · Cited by 3,329
Toll-like receptors in innate immunity
Takeda, K. (2004) · International Immunology · doi:10.1093/intimm/dxh186 · Cited by 3,328 · cited 5×
“…of IFNα / β genes are mediated by the activation of pattern recognition receptors (PRRs) including TLRs (Takeda et al ., 2003; Akira and Takeda, 2004; Takeda and Akira, 2005; Kawai and Akira, 2006) and retinoic acidinducible gene-I (RIG-I) and melanoma differentiationassociated gene 5 (Mda5)…”
BackgroundInfluentialPrinciples of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O., & Akira, S. (2005) · Nature Immunology · doi:10.1038/ni1243 · Cited by 2,562
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., & Tschopp, J. (2005) · Nature · doi:10.1038/nature04193 · Cited by 2,401
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,245
Self-citationNATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113
IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., & Donnelly, R. P. (2003) · Nature Immunology · doi:10.1038/ni875 · Cited by 1,868
VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling
Xu, L.-G., Wang, Y.-Y., Han, K.-J., Li, L.-Y., Zhai, Z., & Shu, H.-B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.08.014 · Cited by 1,853
Pestka, S., Langer, J. A., Zoon, K. C., & Samuel, C. E. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003455 · Cited by 1,825
Der, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
Kawai, T., & Akira, S. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401850 · Cited by 1,810
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808
Interferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,766
Yoneyama, M., Kikuchi, M., Matsumoto, K., Imaizumi, T., Miyagishi, M., Taira, K., Foy, E., Loo, Y.-M., Gale, M., Akira, S., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.2851 · Cited by 1,689
IRF Family of Transcription Factors as Regulators of Host Defense
Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658
Self-citationIPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell Precursors
Liu, Y.-J. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115633 · Cited by 1,625
IL-28, IL-29 and their class II cytokine receptor IL-28R
Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., et al. (2003) · Nature Immunology · doi:10.1038/ni873 · Cited by 1,570
Immune Response in Mice that Lack the Interferon-γ Receptor
Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilček, J., Zinkernagel, R. M., & Aguet, M. (1993) · Science · doi:10.1126/science.8456301 · Cited by 1,548
Viruses and interferon: a fight for supremacy
Katze, M. G., He, Y., & Gale, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri888 · Cited by 1,419
Sato, M., Suemori, H., Hata, N., Asagiri, M., Ogasawara, K., Nakao, K., Nakaya, T., Katsuki, M., Noguchi, S., Tanaka, N., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00053-4 · Cited by 1,339
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
Theofilopoulos, A. N., Baccala, R., Beutler, B., & Kono, D. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115843 · Cited by 1,185
Li, K., Foy, E., Ferreon, J. C., Nakamura, M., Ferreon, A. C. M., Ikeda, M., Ray, S. C., Gale, M., & Lemon, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408824102 · Cited by 1,092
Marie, I. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6660 · Cited by 1,049
THE IFNγ RECEPTOR:A Paradigm for Cytokine Receptor Signaling
Bach, E. A., Aguet, M., & Schreiber, R. D. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.563 · Cited by 1,034
Kawai, T., Sato, S., Ishii, K. J., Coban, C., Hemmi, H., Yamamoto, M., Terai, K., Matsuda, M., Inoue, J.-I., Uematsu, S., et al. (2004) · Nature Immunology · doi:10.1038/ni1118 · Cited by 1,033
Andrejeva, J., Childs, K. S., Young, D. F., Carlos, T. S., Stock, N., Goodbourn, S., & Randall, R. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407639101 · Cited by 992
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures
Goodbourn, S., Didcock, L., & Randall, R. E. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-10-2341 · Cited by 977
Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction
Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C., & Taniguchi, T. (2005) · Nature · doi:10.1038/nature03547 · Cited by 912
Self-citationInterferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
Schindler, C., Shuai, K., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1496401 · Cited by 899
The roles of IFNγ in protection against tumor development and cancer immunoediting
Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00038-7 · Cited by 899
Jaks and Stats in signaling by the cytokine receptor superfamily
Ihle, J. N., & Kerr, I. M. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89000-9 · Cited by 898
A protein tyrosine kinase in the interferon αβ signaling pathway
Velazquez, L., Fellous, M., Stark, G. R., & Pellegrini, S. (1992) · Cell · doi:10.1016/0092-8674(92)90105-l · Cited by 872
Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C
Liang, T. J., Rehermann, B., Seeff, L. B., & Hoofnagle, J. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00008 · Cited by 868
Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., Shibue, T., Honda, K., et al. (2003) · Nature · doi:10.1038/nature01850 · Cited by 847
Self-citationInhibition of Viral Replication by Interferon-γ-Induced Nitric Oxide Synthase
Karupiah, G., Xie, Q.-W., Buller, R. M. L., Nathan, C., Duarte, C., & MacMicking, J. D. (1993) · Science · doi:10.1126/science.7690156 · Cited by 816
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β
Takayanagi, H., Kim, S., Matsuo, K., Suzuki, H., Suzuki, T., Sato, K., Yokochi, T., Oda, H., Nakamura, K., Ida, N., et al. (2002) · Nature · doi:10.1038/416744a · Cited by 717
Cytokine Signaling Through Nonreceptor Protein Tyrosine Kinases
Taniguchi, T. (1995) · Science · doi:10.1126/science.7716517 · Cited by 692
The human interferon $alpha;/$beta; receptor: Characterization and molecular cloning
NOVICK, D. (1994) · Cell · doi:10.1016/0092-8674(94)90154-6 · Cited by 667
Matsuyama, T., Kimura, T., Kitagawa, M., Pfeffer, K., Kawakami, T., Watanabe, N., Kündig, T. M., Amakawa, R., Kishihara, K., Wakeham, A., et al. (1993) · Cell · doi:10.1016/s0092-8674(05)80086-8 · Cited by 649
Rothenfusser, S., Goutagny, N., DiPerna, G., Gong, M., Monks, B. G., Schoenemeyer, A., Yamamoto, M., Akira, S., & Fitzgerald, K. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5260 · Cited by 643
Evasion of intracellular host defence by hepatitis C virus
Gale, M., & Foy, E. M. (2005) · Nature · doi:10.1038/nature04078 · Cited by 633
A critical function for type I interferons in cancer immunoediting
Dunn, G. P., Bruce, A. T., Sheehan, K. C. F., Shankaran, V., Uppaluri, R., Bui, J. D., Diamond, M. S., Koebel, C. M., Arthur, C., White, J. M., et al. (2005) · Nature Immunology · doi:10.1038/ni1213 · Cited by 605
Uzé, G., Lutfalla, G., & Gresser, I. (1990) · Cell · doi:10.1016/0092-8674(90)90738-z · Cited by 574
Positive feedback regulation of type I IFN genes by the IFN‐inducible transcription factor IRF‐7
Sato, M., Hata, N., Asagiri, M., Nakaya, T., Taniguchi, T., & Tanaka, N. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01514-2 · Cited by 553
David, M., Petricoin, E., Benjamin, C., Pine, R., Weber, M. J., & Larner, A. C. (1995) · Science · doi:10.1126/science.7569900 · Cited by 543
Honda, K., Yanai, H., Mizutani, T., Negishi, H., Shimada, N., Suzuki, N., Ohba, Y., Takaoka, A., Yeh, W.-C., & Taniguchi, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406933101 · Cited by 525
Self-citationSymons, J. A., Alcamí, A., & Smith, G. L. (1995) · Cell · doi:10.1016/0092-8674(95)90076-4 · Cited by 490
Uematsu, S., Sato, S., Yamamoto, M., Hirotani, T., Kato, H., Takeshita, F., Matsuda, M., Coban, C., Ishii, K. J., Kawai, T., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042372 · Cited by 488
A weak signal for strong responses: interferon-alpha/beta revisited
Taniguchi, T., & Takaoka, A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35073080 · Cited by 483
Self-citationChang, H. W., Watson, J. C., & Jacobs, B. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4825 · Cited by 483
Taniguchi, T., & Takaoka, A. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00305-3 · Cited by 482
Self-citationA46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling
Bowie, A., Kiss-Toth, E., Symons, J. A., Smith, G. L., Dower, S. K., & O'Neill, L. A. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160027697 · Cited by 466
The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion
Levy, D. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00027-7 · Cited by 428 · cited 3×
“On the other hand, it has become clearer that there are multiple strategies that viruses evolve for the evasion from the IFN system (Goodbourn et al ., 2000; Levy and Garcia-Sastre, 2001; GarciaSastre, 2002; Katze et al ., 2002; Weber et al ., 2004; Johnson and Gale, 2005).”
BackgroundDidcock, L., Young, D. F., Goodbourn, S., & Randall, R. E. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.9928-9933.1999 · Cited by 422
Interferons and other regulatory cytokines
Demaeyer, E. M., & Maeyer‐Guignard, J. D. (1988) · Medical Entomology and Zoology · Cited by 419
Colamonici, O. R., Domanski, P., Sweitzer, S. M., Larner, A., & Buller, R. M. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.15974 · Cited by 386
Goh, K. C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.20.5601 · Cited by 379
Interferon-induced nuclear signalling by Jak protein tyrosine kinases
Silvennoinen, O., Ihle, J. N., Schlessinger, J., & Levy, D. E. (1993) · Nature · doi:10.1038/366583a0 · Cited by 376
Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor.
Decker, T., Lew, D. J., Mirkovitch, J., & Darnell, J. E. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb08026.x · Cited by 374
Stack, J., Haga, I. R., Schröder, M., Bartlett, N. W., Maloney, G., Reading, P. C., Fitzgerald, K. A., Smith, G. L., & Bowie, A. G. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041442 · Cited by 369
Interferons and Other Cytokines
Hendrzak, J. A., & Brunda, M. J. (1997) · Cancer Therapeutics · doi:10.1007/978-1-59259-717-8_13 · Cited by 356
Cross Talk Between Interferon-γ and -α/β Signaling Components in Caveolar Membrane Domains
Takaoka, A., Mitani, Y., Suemori, H., Sato, M., Yokochi, T., Noguchi, S., Tanaka, N., & Taniguchi, T. (2000) · Science · doi:10.1126/science.288.5475.2357 · Cited by 319
Self-citationKessler, D. S., Veals, S. A., Fu, X. Y., & Levy, D. E. (1990) · Genes & Development · doi:10.1101/gad.4.10.1753 · Cited by 312 · cited 2×
“…the nucleus; subsequently, AAF and ISGF3 bind to their specific DNA sequences containing each of the common motifs, namely, the IFN-γ-activated sequence (GAS; Decker et al., 1991b; Lew et al., 1991) and the IFN-stimulated regulatory element (ISRE; Kessler et al., 1990; Williams, 1991) respectively.”
BackgroundProduction of type I interferons
Asselin-Paturel, C., & Trinchieri, G. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051395 · Cited by 305
Interferons and other regulatory cytokines
Meager, A. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90301-3 · Cited by 304
Encoding of a Homolog of the IFN-γ Receptor by Myxoma Virus
Upton, C., Mossman, K., & McFadden, G. (1992) · Science · doi:10.1126/science.1455233 · Cited by 304
Alcamí, A., & Smith, G. L. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4633-4639.1995 · Cited by 301
Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells
Buller, R. M. L., Holmes, K. L., Hügin, A., Frederickson, T. N., & Morse, H. C. (1987) · Nature · doi:10.1038/328077a0 · Cited by 300
The Role of Stat4 in Species-Specific Regulation of Th Cell Development by Type I IFNs
Rogge, L., D’Ambrosio, D., Biffi, M., Penna, G., Minetti, L. J., Presky, D. H., Adorini, L., & Sinigaglia, F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6567 · Cited by 298
Interferon-κ, a Novel Type I Interferon Expressed in Human Keratinocytes
LaFleur, D. W., Nardelli, B., Tsareva, T., Mather, D., Feng, P., Semenuk, M., Taylor, K., Buergin, M., Chinchilla, D., Roshke, V., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102502200 · Cited by 288
Lew, D. J., Decker, T., Strehlow, I., & Darnell, J. E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.1.182 · Cited by 280
Pfeffer, L. M., Mullersman, J. E., Pfeffer, S. R., Murti, A., Shi, W., & Yang, C. H. (1997) · Science · doi:10.1126/science.276.5317.1418 · Cited by 258
Hida, S., Ogasawara, K., Sato, K., Abe, M., Takayanagi, H., Yokochi, T., Sato, T., Hirose, S., Shirai, T., Taki, S., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00064-9 · Cited by 251
Nguyen, H., Ramana, C. V., Bayes, J., & Stark, G. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105070200 · Cited by 247
Activation of the p38 Mitogen-activated Protein Kinase by Type I Interferons
Uddin, S., Majchrzak, B., Woodson, J., Arunkumar, P., Alsayed, Y., Pine, R., Young, P. R., Fish, E. N., & Platanias, L. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30127 · Cited by 227
Inverse Interference: How Viruses Fight the Interferon System
Weber, F., Kochs, G., & Haller, O. (2004) · Viral Immunology · doi:10.1089/vim.2004.17.498 · Cited by 217
Uddin, S., Sassano, A., Deb, D. K., Verma, A., Majchrzak, B., Rahman, A., Malik, A. B., Fish, E. N., & Platanias, L. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109671200 · Cited by 215
Davies, M. V., Elroy-Stein, O., Jagus, R., Moss, B., & Kaufman, R. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.1943-1950.1992 · Cited by 214
Yang, C. H., Murti, A., Pfeffer, S. R., Kim, J. G., Donner, D. B., & Pfeffer, L. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011006200 · Cited by 200
Uddin, S., Yenush, L., Sun, X.-J., Sweet, M. E., White, M. F., & Platanias, L. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.15938 · Cited by 199
The Class II cytokine receptor (CRF2) family: overview and patterns of receptor–ligand interactions
Langer, J. A., Cutrone, E. C., & Kotenko, S. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.001 · Cited by 193
Uddin, S., Lekmine, F., Sharma, N., Majchrzak, B., Mayer, I., Young, P. R., Bokoch, G. M., Fish, E. N., & Platanias, L. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003170200 · Cited by 191
Interferons: mechanisms of action and clinical applications
Parmar, S., & Platanias, L. C. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200311000-00005 · Cited by 190
Pestka, S. (1997) · PubMed · Cited by 189
Transcriptional regulation of interferon‐stimulated genes
WILLIAMS, B. R. G. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb21041.x · Cited by 180
The Evolution of the Type I Interferons1
ROBERTS, R. M., LIU, L., GUO, Q., LEAMAN, D., & BIXBY, J. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.805 · Cited by 170
Chronic Hepatitis B Virus Infection: Treatment Strategies for the Next Millennium
Malik, A. H., & Lee, W. M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00007 · Cited by 167
Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication
Harris, N., Buller, R. M., & Karupiah, G. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.910-915.1995 · Cited by 163
Mayer, I. A., Verma, A. K., Grumbach, I. M., Shahab Uddin, M. S., Lekmine, F., Ravandi, F., Majchrzak, B., Fujita, S., Fish, E. N., & Platanias, L. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011685200 · Cited by 162
ISGF3γ p48, a specificity switch for interferon activated transcription factors
Bluyssen, H. A. R. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/1359-6101(96)00005-6 · Cited by 158
The human interferon ? species and receptors
Pestka, S. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:4<254::aid-bip1001>3.0.co;2-1 · Cited by 157
Abramovich, C., Shulman, L. M., Ratovitski, E. A., Harroch, S., Tovey, M. G., Eid, P., & Revel, M. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06932.x · Cited by 153
Importance of interferons in recovery from mousepox
Karupiah, G., Fredrickson, T. N., Holmes, K. L., Khairallah, L. H., & Buller, R. M. L. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.4214-4226.1993 · Cited by 141
Yetter, A., Shahab Uddin, M. S., Krolewski, J. J., Jiao, H., Yi, T., & Platanias, L. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18179 · Cited by 136
Decker, T., Lew, D. J., & Darnell, J. E., Jr. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.10.5147 · Cited by 134
Yang, C., Murti, A., & Pfeffer, L. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5568 · Cited by 134
Interferon messenger RNA is produced constitutively in the organs of normal individuals.
Tovey, M. G., Streuli, M., Gresser, I., Gugenheim, J., Blanchard, B., Guymarho, J., Vignaux, F., & Gigou, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.14.5038 · Cited by 133
Burfoot, M. S., Rogers, N. C., Watling, D., Smith, J. M., Pons, S., Paonessaw, G., Pellegrini, S., White, M. F., & Kerr, I. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24183 · Cited by 133
A species of human alpha interferon that lacks the ability to boost human natural killer activity.
Ortaldo, J. R., Herberman, R. B., Harvey, C., Osheroff, P. L., Pan, Y.-C. E., Kelder, B., & Pestka, S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.15.4926 · Cited by 133
Ichikawa, E., Hida, S., Omatsu, Y., Shimoyama, S., Takahara, K., Miyagawa, S., Inaba, K., & Taki, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400610101 · Cited by 132
Signal transduction in the interferon system.
Haque, S. J., & Williams, B. R. G. (1998) · PubMed · Cited by 130
Transcriptional Responses to Polypeptide Ligands: The JAK-STAT Pathway
Stevens, R. C. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.64.1.621 · Cited by 130
DUMOUTIER, L., LEJEUNE, D., HOR, S., FICKENSCHER, H., & RENAULD, J.-C. (2003) · Biochemical Journal · doi:10.1042/bj20021935 · Cited by 128 · cited 1×
“In particular, type III IFNs were reported to activate Stat1 and Stat2 through the activation of as-yet determined Jak kinase(s), leading to downstream gene induction in an ISGF3- or GAF/AAF-dependent manner (Dumoutier et al., 2003; Kotenko et al., 2003).”
BackgroundCARD games between virus and host get a new player
Johnson, C., & Gale, M. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.11.004 · Cited by 128
Activation of a CrkL-Stat5 Signaling Complex by Type I Interferons
Fish, E. N., Shahab Uddin, M. S., Korkmaz, M., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.571 · Cited by 127
Mechanisms of inhibition of the host interferon α/β-mediated antiviral responses by viruses
García‐Sastre, A. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01583-6 · Cited by 127
Differential Responses to IFN-α Subtypes in Human T Cells and Dendritic Cells
Hilkens, C. M. U., Schlaak, J., & Kerr, I. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5255 · Cited by 126
Vilček, J. (2002) · Nature Immunology · doi:10.1038/ni0103-8 · Cited by 126
The Type I Interferon Receptor Mediates Tyrosine Phosphorylation of Insulin Receptor Substrate 2
Platanias, L. C., Shahab Uddin, M. S., Yetter, A., Sun, X., & White, M. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.278 · Cited by 124
Thyrell, L., Hjortsberg, L., Arulampalam, V., Panaretakis, T., Uhles, S., Dagnell, M., Zhivotovsky, B., Leibiger, I. B., Grandér, D., & Tamm, K. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312219200 · Cited by 124
Diversity and Relatedness Among the Type I Interferons
Chen, J., Baig, E., & Fish, E. N. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2004.24.687 · Cited by 122
Limitin: An interferon-like cytokine that preferentially influences B-lymphocyte precursors
Oritani, K., Medina, K. L., Tomiyama, Y., Ishikawa, J., Okajima, Y., Ogawa, M., Yokota, T., Aoyama, K., Takahashi, I., Kincade, P. W., et al. (2000) · Nature Medicine · doi:10.1038/76233 · Cited by 121
Constitutive IFN-α/β Signal for Efficient IFN-α/β Gene Induction by Virus
Hata, N., Sato, M., Takaoka, A., Asagiri, M., Tanaka, N., & Taniguchi, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5159 · Cited by 121
Self-citationImmunodeficient mice recover from infection with vaccinia virus expressing interferon‐γ
Kohonen‐Corish, M. R. J., King, N. J. C., Woodhams, C. E., & Ramshaw, I. A. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200123 · Cited by 115
Biologic Effects of Interferons
Gresser, I. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12874776 · Cited by 109
Mitani, Y., Takaoka, A., Kim, S. H., Kato, Y. H., Yokochi, T., Tanaka, N., & Taniguchi, T. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00448.x · Cited by 108
Self-citationHonda, K., Mizutani, T., & Taniguchi, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307336101 · Cited by 107
Karupiah, G., Blanden, R. V., & Ramshaw, I. A. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.5.1495 · Cited by 106
Issues in T‐helper 1 development – resolved and unresolved
Berenson, L. S., Ota, N., & MURPHY, K. M. M. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00208.x · Cited by 103
Evasion of innate immunity by vaccinia virus
Haga, I. R., & Bowie, A. (2005) · Parasitology · doi:10.1017/s0031182005008127 · Cited by 101
Other Kinases Can Substitute for Jak2 in Signal Transduction by Interferon-γ
Kotenko, S. V., Izotova, L. S., Pollack, B. P., Muthukumaran, G., Paukku, K., Silvennoinen, O., Ihle, J. N., & Pestka, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17174 · Cited by 97
Silencing STATs: lessons from paramyxovirus interferon evasion
Horvath, C. M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.02.003 · Cited by 96
Wang, K., Scheel‐Toellner, D., Wong, S. H., Craddock, R. M., Caamaño, J., Akbar, A. N., Salmon, M., & Lord, J. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.1035 · Cited by 95
New aspects of IFN‐α/β signalling in immunity, oncogenesis and bone metabolism
Takaoka, A., & Taniguchi, T. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01455.x · Cited by 91
Self-citationTo Interfere and to Anti-interfere: The Interplay Between Hepatitis C Virus and Interferon
He, Y., & Katze, M. G. (2002) · Viral Immunology · doi:10.1089/088282402317340260 · Cited by 83
Wang, J., Pham-Mitchell, N., Schindler, C., & Campbell, I. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18637 · Cited by 82
Haque, S. J., & Williams, B. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32200-7 · Cited by 77
The physiological interferon response
Bocci, V. A. (1985) · Immunology Today · doi:10.1016/0167-5699(85)90159-8 · Cited by 77
Shahab Uddin, M. S., Majchrzak, B., Wang, P.-C., Modi, S., Khan, M. K., Fish, E. N., & Platanias, L. C. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2402 · Cited by 75
TheJanusprotein tyrosine kinases in hematopoietic cytokine signaling
Ihle, J. N. (1995) · Seminars in Immunology · doi:10.1006/smim.1995.0029 · Cited by 69
Requirement of the IFN‐α/β‐induced CXCR3 chemokine signalling for CD8+ T cell activation
Ogasawara, K., Hida, S., Weng, Y., Saiura, A., Sato, K., Takayanagi, H., Sakaguchi, S., Yokochi, T., Kodama, T., Naitoh, M., et al. (2002) · Genes to Cells · doi:10.1046/j.1365-2443.2002.00515.x · Cited by 66
Hou, S., Mo, X. Y., Hyland, L., & Doherty, P. C. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1429-1434.1995 · Cited by 63
Alcamı́, A., & Smith, G. L. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10051-2 · Cited by 56
Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice
Taki, S. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00023-0 · Cited by 53
Interferon beta promotes survival in primary astrocytes through phosphatidylinositol 3-kinase
Barca‐Mayo, O. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00160-7 · Cited by 51
Soluble interferon-γ receptors encoded by poxviruses
Alcamı́, A., & Smith, G. L. (1996) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/0147-9571(96)00013-6 · Cited by 44
Liptáková, H., Kontseková, E., Alcamı́, A., Smith, G. L., & KONTSEK, P. (1997) · Virology · doi:10.1006/viro.1997.8527 · Cited by 37
Berenson, L. S., Farrar, J. D., Murphy, T. L., & MURPHY, K. M. M. (2004) · European Journal of Immunology · doi:10.1002/eji.200324829 · Cited by 35
Cited by
A diverse range of gene products are effectors of the type I interferon antiviral response
Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011) · Nature · doi:10.1038/nature09907 · Cited by 2,433
Brass, A. L., Huang, I.-C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L., Fikrig, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.12.017 · Cited by 1,269
Teixeira, L., Ferreira, Á., & Ashburner, M. (2008) · PLoS Biology · doi:10.1371/journal.pbio.1000002 · Cited by 1,214
Distinct RIG-I and MDA5 Signaling by RNA Viruses in Innate Immunity
Loo, Y.-M., Fornek, J., Crochet, N., Bajwa, G., Perwitasari, O., Martinez-Sobrido, L., Akira, S., Gill, M. A., García-Sastre, A., Katze, M. G., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01080-07 · Cited by 1,071
“Despite differences in genomic features and replication strategies, RNA viruses can trigger common cellular components during infection to elicit an innate immune response that serves as a first line of protection against infection (18, 38, 41).”
BackgroundSystems biology of vaccination for seasonal influenza in humans
Nakaya, H. I., Wrammert, J., Lee, E. K., Racioppi, L., Marie-Kunze, S., Haining, W. N., Means, A. R., Kasturi, S. P., Khan, N., Li, G.-M., et al. (2011) · Nature Immunology · doi:10.1038/ni.2067 · Cited by 809
Metadata
- Authors
- Takaoka, A., & Yanai, H.
- Venue
- Cellular Microbiology
- Publisher
- Hindawi Limited
- Published
- 2006-06
- Volume
- 8
- Issue
- 6
- Pages
- 907-922
- ISSN
- 1462-5814 (ISSN-L)
- 1462-5822
- OpenAlex
- W2015544673
- Cited by
- 581
- References
- 147
- FWCI
- 15.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.